The Clinical Study of Hemoptysis in Lung Disease

Lee, Hyang Ju; Um, Hye Suk; Kim, Jung Tae; Cho, dong Ill; Rhu, Nam Soo

doi:10.4046/trd.2000.49.6.760

Cited by 3 publications

(3 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…However, in pediatric cases, major causative factors include infection, foreign body aspiration, and congenital heart diseases 4. In contrast, in Korea, pulmonary tuberculosis, lung cancer, and telangiectasia are causative factors for hemoptysis in adults 5. In Korean pediatric patients, despite the publication of some cases,6-8 major causative diseases for hemoptysis have not yet been reported.…”

Section: Introductionmentioning

confidence: 99%

“… 4 In contrast, in Korea, pulmonary tuberculosis, lung cancer, and telangiectasia are causative factors for hemoptysis in adults. 5 In Korean pediatric patients, despite the publication of some cases, 6 - 8 major causative diseases for hemoptysis have not yet been reported. In this study, we analyzed the etiologies and clinical characteristics of hemoptysis in Korean children.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Etiology of Hemoptysis in Children: A Single Institutional Series of 40 Cases

Sim

Kim

Lee

et al. 2009

Allergy Asthma Immunol Res

View full text Add to dashboard Cite

PurposeThe aim of this study was to determine the causes of hemoptysis in a pediatric age group.MethodsWe conducted a retrospective chart review of all patients who were admitted to Samsung Medical Center between 1996 and 2008 with a chief complaint of hemoptysis. Patients with trauma or underlying bleeding tendency such as leukemia were excluded. Patients were divided into three groups according to age (0 to 5 yr, 6 to 10 yr, and 11 to 18 yr). The amount of hemoptysis was classified as mild (≤20 mL/day), moderate (20-100 mL/day), or massive (>100 mL/day). Causes and duration of hemoptysis, disease course, and mortality were also investigated.ResultsA total of 40 patients (18 males and 22 females) were identified. Their median age was 6.3 yr (range, 10 months to 18 yr). Twenty-five patients manifested mild hemoptysis; moderate and massive hemoptysis were found in nine and six patients, respectively. Respiratory tract infection was the most common cause of hemoptysis. Other causes included congenital heart disease, Heiner syndrome, neoplasm in the airway, vasculitis syndrome, and bronchiectasis. In most patients (87.5%), hemoptysis disappeared during medical treatment that included antibiotics or transfusion. Hemoptysis recurred in 12 patients, and the overall mortality rate was 5%.ConclusionsThe most common cause of hemoptysis in children was respiratory tract infection. Most cases had a benign course, but recurrence and mortality occurred in a minority of patients. An accurate diagnosis of the underlying etiology is essential for treatment.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Etiology of Hemoptysis in Children: A Single Institutional Series of 40 Cases

Sim

Kim

Lee

et al. 2009

Allergy Asthma Immunol Res

View full text Add to dashboard Cite

show abstract

“…특이적인 치료가 필요 한 활동성 폐결핵, 폐암 등과는 달리 기관지염, 비활동성 폐결핵 및 그와 관련된 합병증, 그리고 기관지확장증 등과 같이 기도 염증과 연관된 질환에서는 3 고식적인 내과적 치료 및 반복적인 객혈이 있을 시에는 외과적 절제술이 고려된다 4,5 . 그러나 외과적 절제술은 절제 가능한 경우에 만 시행하는 것으로 흔히 양측성 병변, 폐기능 및 전신상 태 불량 등으로 수술적 치료 적응에 해당되지 않는 경우가 많다 6 . 따라서 기관지염, 기관지확장증, 아스페르길루스 종, 비활동성 폐결핵 등의 원인 질환에서는 대부분 보존적 치료가 시행된다.…”

Section: 서 론unclassified

The Effect of Corticosteroid in Conservative Treatment of Patients with Hemoptysis

et al. 2007

View full text Add to dashboard Cite

Background: This study examined the effect of corticosteroids as a short-term treatment for patients with hemoptysis that requires conservative treatment including bed rest, antitussives and antibiotics. Methods: From February 2005 to August 2006, 78 consecutive patients who visited the emergency room because of hemoptysis were enrolled in the study. Patients with hemoptysis due to lung cancer, active pulmonary tuberculosis, and pneumonia were excluded. The 78 patients were divided randomly into a corticosteroid medication group (n=37) and a control group (n=41). The mean control time of hemoptysis, mean in-hospital days, and complications of treatment were investigated prospectively. Results: For the etiology of hemoptysis, inactive pulmonary tuberculosis alone or its associated complications (bronchiectasis and/or aspergilloma) were the most common causes (51%); bronchiectasis alone and bronchitis were the next most common causative diseases (15%, respectively). The patients' characteristics and symptoms in the corticosteroid medication and control groups were similar. The steroid medication group showed a significantly lower mean control time of hemoptysis than the control group (4.0±2.7 days, 6.1±4.8 days, respectively) (p=0.022) and had a lower mean number of in-hospital days (5.8±3.4 days, 7.9±4.8 days, respectively) (p=0.036). There were no significant complications, such as hospital-acquired pneumonia or gastrointestinal bleeding, related to the use of corticosteroids. Conclusion: The use of corticosteroids as a conservative treatment for hemoptysis due to bronchitis, bronchiectasis, inactive pulmonary tuberculosis and its related complications safely reduces the control time of hemoptysis as well as the number of in-hospital days.

show abstract

A Case Report of a Patient with Hemoptysis Diagnosed with Bronchiectasis Treated with Hyunggaeyungyo-tang Plus Gamijihwang-tang

도¹,

김²,

유³

et al. 2018

J Int Korean Med

View full text Add to dashboard Cite

Objective: This case report describes the treatment of hemoptysis in a bronchiectasis patient with Hyunggaeyungyo-tang plus Gamijihwang-tang.Methods: The hemoptysis in this patient was suspected to result from bronchiectasis, which was diagnosed with a chest CT at another hospital. She was treated with a herbal medicine, Hyunggaeyungyo-tang, plus Gamijihwang-tang. The effectiveness of the treatment was evaluated by measuring the amount of hemoptysis and by a visual analogue scale (VAS) to determine the patient's quality of life.Results: After administration of Hyunggaeyungyo-tang plus Gamijihwang-tang, the severity of hemoptysis decreased, based on the amount of hemoptysis and the VAS scores.Conclusions: Hyunggaeyungyo-tang plus Gamijihwang-tang is a potent therapeutic agent for the treatment of hemoptysis.

show abstract

The Clinical Study of Hemoptysis in Lung Disease

Cited by 3 publications

References 0 publications

Etiology of Hemoptysis in Children: A Single Institutional Series of 40 Cases

Etiology of Hemoptysis in Children: A Single Institutional Series of 40 Cases

The Effect of Corticosteroid in Conservative Treatment of Patients with Hemoptysis

A Case Report of a Patient with Hemoptysis Diagnosed with Bronchiectasis Treated with Hyunggaeyungyo-tang Plus Gamijihwang-tang

Contact Info

Product

Resources

About